(S (NP-SBJ (NP The/DT (ADJP transcriptionally/RB active/JJ) factors/NNS) (VP mediating/VBG (NP (NP the/DT effect/NN) (PP of/IN (NP the/DT HTLV-I/NN Tax/NN transactivator/NN)) (PP on/IN (NP the/DT IL-2R/NN alpha/NN kappa/NN B/NN enhancer/NN))))) (VP include/VBP (NP (NP the/DT product/NN) (PP of/IN (NP the/DT c-rel/NN proto-oncogene/NN)))) ./.)
(S (NP-SBJ The/DT transactivator/NN HTLV-I/NN Tax/NN) (VP activates/VBZ (NP (NP the/DT promoter/NN) (PP of/IN (NP (NP the/DT gene/NN) (VP coding/VBG (PP for/IN (NP (NP the/DT interleukin/NN 2/CD alpha-chain/JJ receptor/NN) (PRN -LRB-/-LRB- (NP IL-2R/NN alpha/NN) -RRB-/-RRB-))) (PP via/IN (NP (NP a/DT kappa/NN B/NN site/NN) (SBAR (WHNP-38 that/WDT) (S (NP-SBJ *T*-38/-NONE-) (VP can/MD (VP bind/VB (NP (NP several/JJ protein/NN species/NNS) (PP of/IN (NP the/DT rel/NN family/NN)))))))))))))) ./.)
(S (NP-SBJ Tax1/NN) (ADVP strongly/RB) (VP activates/VBZ (NP (NP the/DT enhancer/NN activity/NN) (PP of/IN (NP this/DT motif/NN))) ,/, (PP in/IN (NP (NP-COOD both/CC (NP epithelial/JJ HeLa/NN) and/CC (NP lymphoid/JJ Jurkat/NN)) cells/NNS))) ./.)
(S (NP-SBJ-39 This/DT activation/NN) (VP was/VBD not/RB (VP observed/VBN (NP *-39/-NONE-) (PP in/IN (NP undifferentiated/JJ embryocarcinoma/NN F9/NN cells/NNS)))) ./.)
(S (NP-SBJ (NP Overexpression/NN) (PP of/IN (NP (NP the/DT (NP-COOD (NP p50/NN) ,/, (NP p65/NN) and/CC (NP Rel/NN)) proteins/NNS) (PP in/IN (NP these/DT cells/NNS))))) (VP showed/VBD (SBAR that/IN (S (NP-SBJ-40 (NP significant/JJ activation/NN) (PP of/IN (NP the/DT IL-2R/NN alpha/NN kappa/NN B/NN site/NN))) (VP was/VBD (VP observed/VBN (NP *-40/-NONE-) (PP only/RB with/IN (NP-COOD (NP Rel/NN) and/CC (NP-COOD (NP Rel/NN) plus/CC (NP p65/NN))))))))) ./.)
(S (ADVP Moreover/RB) ,/, (SBAR whereas/IN (S (NP-SBJ-COOD-41 both/CC (NP Tax/NN) and/CC (NP (NP phorbol/NN 12-myristate/NN 13-acetate/NN) (PRN -LRB-/-LRB- (NP PMA/NN) -RRB-/-RRB-))) (VP are/VBP (ADJP-PRD able/JJ (S (NP-SBJ *-41/-NONE-) (VP to/TO (VP (ADVP efficiently/RB) induce/VB (NP (NP the/DT binding/NN) (PP of/IN (NP NF-kappa/NN B/NN)) (PP to/TO (NP the/DT IL-2R/NN alpha/NN kappa/NN B/NN site/NN)))))))))) ,/, (NP-SBJ PMA/NN) (VP is/VBZ (ADVP functionally/RB) (ADJP-PRD inactive/JJ)) ./.)
(S (S (NP-SBJ *-42/-NONE-) (VP Using/VBG (NP the/DT DNA/NN affinity/NN precipitation/NN assay/NN))) ,/, (NP-SBJ-42 we/PRP) (VP observed/VBD (SBAR that/IN (S-COOD (S (NP-SBJ-43 Tax1/NN) (VP is/VBZ (ADJP-PRD able/JJ (S (NP-SBJ *-43/-NONE-) (VP to/TO (VP (ADVP efficiently/RB) induce/VB (NP (NP the/DT binding/NN) (PP of/IN (NP Rel/NN))))))))) ,/, whereas/IN (S (NP-SBJ PMA/NN) (VP is/VBZ not/RB (ADJP-PRD *?*/-NONE-)))))) ./.)
(S (NP-SBJ-44 This/DT) (VP established/VBD (NP (NP a/DT clear/JJ difference/NN) (PP between/IN (NP both/DT stimuli/NNS))) ,/, (S (NP-SBJ *-44/-NONE-) (VP indicating/VBG (SBAR that/IN (S (NP-SBJ Rel/NN) (VP is/VBZ (NP-PRD the/DT (ADJP functionally/RB active/JJ) factor/NN))))))) ./.)
(S (NP-SBJ We/PRP) (VP conclude/VBP (PP from/IN (NP these/DT results/NNS)) (SBAR-COOD (SBAR that/IN (S (NP-SBJ-45 (NP the/DT functional/JJ activity/NN) (PP of/IN (NP (NP members/NNS) (PP of/IN (NP the/DT rel/NN family/NN))))) (VP is/VBZ (VP regulated/VBN (NP *-45/-NONE-) (PP by/IN (NP-LGS (NP their/PRP$ interaction/NN) (PP with/IN (NP DNA/NN)))))))) and/CC (SBAR that/IN (S (NP-SBJ Rel/NN) (VP can/MD (VP be/VB (NP-PRD a/DT potent/JJ transcriptional/JJ activator/NN) (PP on/IN (NP specific/JJ kappa/NN B/NN sites/NNS)))))))) ./.)
